Eisai
4523.T
#2011
Rank
HK$60.58 B
Marketcap
HK$214.91
Share price
-0.53%
Change (1 day)
-43.13%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): HK$17.10

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$16.96. In 2022 the company made an earnings per share (EPS) of HK$12.45 a decrease over its 2021 EPS that were of HK$55.28.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$17.1037.3%
2022HK$12.45-77.48%
2021HK$55.28-41.88%
2020HK$95.11-0.94%
2019HK$96.0252.59%
2018HK$62.92124.17%
2017HK$28.07-49.42%
2016HK$55.5037.08%
2015HK$40.49-11.75%
2014HK$45.88-3.23%
2013HK$47.41-18.56%
2012HK$58.22-15.51%
2011HK$68.91-3.75%
2010HK$71.59-1.36%
2009HK$72.58